11/14/2024
8:00 PM | Pliant Therapeutics (Subject)
Redmile Group, LLC (Filed by)
| Form SC 13G | |
11/12/2024
10:53 AM | Laurion Capital Management LP (Filed by)
Pliant Therapeutics (Subject)
| Form SC 13G/A | |
10/04/2024
4:34 PM | Paradigm Biocapital Advisors LP (Filed by)
Pliant Therapeutics (Subject)
| Form SC 13G | |
09/27/2024
3:11 PM | Pliant Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
3:13 PM | Pliant Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/15/2024
10:54 AM | Pliant Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/12/2024
5:37 PM | Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
07/12/2024
5:41 PM | Hull Hans (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2024
5:45 PM | Lefebvre Eric (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2024
5:15 PM | Ouimette Mike (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2024
5:22 PM | Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
4:01 PM | Lefebvre Eric (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
3:47 PM | Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
3:54 PM | Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
3:41 PM | Ouimette Mike (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
7:15 PM | Curnutte John T (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
7:15 PM | Bruhn Suzanne Louise (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
7:15 PM | CROWELL GAYLE A (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
7:15 PM | Cline Darren S (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
7:15 PM | Pliant Therapeutics (Issuer)
Shah Smital (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
7:16 PM | Pliant Therapeutics (Issuer)
PYOTT DAVID E I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
7:16 PM | Huh Hoyoung (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
7:16 PM | Knobil Katharine (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
7:16 PM | MCCOURT Thomas A (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
6:57 PM | Krognes Steve E. (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
6:52 PM | Krognes Steve E. (Reporting)
Pliant Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/14/2024
6:43 AM | Pliant Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2024
3:27 PM | Pliant Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2024
5:02 AM | Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
6:45 AM | Pliant Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2024
3:20 PM | Pliant Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/14/2024
7:55 PM | Blue Owl Capital Holdings LP (Filed by)
Pliant Therapeutics (Subject)
| Form SC 13G | |
02/14/2024
4:10 PM | First Light Asset Management, LLC (Filed by)
Pliant Therapeutics (Subject)
| Form SC 13G | |
02/14/2024
7:52 AM | Deep Track Capital, LP (Filed by)
Pliant Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
8:28 AM | FMR LLC (Filed by)
Pliant Therapeutics (Subject)
| Form SC 13G/A | |
02/08/2024
11:29 AM | Laurion Capital Management LP (Filed by)
Pliant Therapeutics (Subject)
| Form SC 13G | |
02/05/2024
6:31 AM | Pliant Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/25/2024
3:59 PM | BlackRock Inc. (Filed by)
Pliant Therapeutics (Subject)
| Form SC 13G | |
01/24/2024
3:56 PM | Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
4:18 PM | Lefebvre Eric (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
4:19 PM | Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
📉 Warning: Market Crash Predicted - Secure Your Savings (Ad) The last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%. Take these 4 steps to protect your retirement here >>> |
01/19/2024
4:19 PM | Hull Hans (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
4:19 PM | Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
4:11 PM | Ouimette Mike (Reporting)
Pliant Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
